MSH|^~\&|SendAppName^2.16.840.1.114222.nnnn^ISO|Sending-Facility^2.16.840.1.114222.nnnn^ISO|PHINCDS^2.16.840.1.114222.4.3.2.10^ISO|PHIN^2.16.840.1.114222^ISO|20141225120030.1234-0500||ORU^R01^ORU_R01|CONSYPH_V1_0_TM_TC04|T|2.5.1|||||||||NOTF_ORU_v3.0^PHINProfileID^2.16.840.1.114222.4.10.3^ISO~Generic_MMG_V2.0^PHINMsgMapID^2.16.840.1.114222.4.10.4^ISO~CongenitalSyphilis_MMG_V1.0^PHINMsgMapID^2.16.840.1.114222.4.10.4^ISOPID|1||CONSYPH_TC04^^^SendAppName&2.16.840.1.114222.nnnn&ISO||~^^^^^^S||20131201|M||2054-5^Black or African American^CDCREC|^^^17^60643^^^^17031|||||||||||2186-5^Not Hispanic or Latino^CDCREC|||||||20131201NK1|1||MTH^Mother^HL70063|^^^17^60643^USA^^^17031||||||||||U^Unknown^HL70002||19900810||||||||||||2186-5^Not Hispanic or Latino^CDCREC|||||||2054-5^Black or African American^CDCRECOBR|1||CONSYPH_TC04^SendAppName^2.16.840.1.114222.nnnn^ISO|68991-9^Epidemiologic Information^LN|||20131220170100|||||||||||||||20131220170100|||F||||||10316^Syphilis, Congenital^NNDOBX|1|CWE|78746-5^Country of Birth^LN||USA^United States^ISO3166_1||||||FOBX|2|CWE|77983-5^Country of Usual Residence^LN||USA^United States^ISO3166_1||||||FOBX|3|TS|77975-1^Diagnosis Date^LN||20131201||||||FOBX|4|CWE|77974-4^Hospitalized^LN||N^No^HL70136||||||FOBX|5|CWE|77978-5^Subject Died^LN||Y^Yes^HL70136||||||FOBX|6|ST|77993-4^State Case Identifier^LN||<use state-assigned value>||||||FOBX|7|ST|77997-5^Legacy Case Identifier^LN||61528936181002006||||||FOBX|8|SN|77998-3^Age at Case Investigation^LN||^1|d^day^UCUM|||||FOBX|9|CWE|77982-7^Case Disease Imported Code^LN||PHC244^Indigenous, within jurisdiction^CDCPHINVS||||||FOBX|10|CWE|77984-3^Country of Exposure^LN|1|USA^United States^ISO3166_1||||||FOBX|11|CWE|77985-0^State or Province of Exposure^LN|1|17^Illinois^FIPS5_2||||||FOBX|12|ST|77986-8^City of Exposure^LN|1|Chicago||||||FOBX|13|ST|77987-6^County of Exposure^LN|1|Cook||||||FOBX|14|CWE|77989-2^Transmission Mode^LN||417409004^Transplacental transmission^SCT||||||FOBX|15|CWE|77990-0^Case Class Status Code^LN||410605003^Confirmed present^SCT||||||FOBX|16|CWE|77965-2^Immediate National Notifiable Condition^LN||N^No^HL70136||||||FOBX|17|CWE|77980-1^Case Outbreak Indicator^LN||N^No^HL70136||||||FOBX|18|ST|77969-4^Jurisdiction Code^LN||S01||||||FOBX|19|CWE|48766-0^Reporting Source Type Code^LN||PHC1225^Labor and Delivery^CDCPHINVS||||||FOBX|20|ST|52831-5^Reporting Source Zip Code^LN||60643||||||FOBX|21|ST|74549-7^Person Reporting to CDC-Name^LN||Darvin, Tom||||||FOBX|22|ST|74548-9^Person Reporting to CDC-Phone Number^LN||(734)677-7777||||||FOBX|23|DT|77979-3^Case Investigation Start Date^LN||20131201||||||FOBX|24|DT|77995-9^Date Reported^LN||20131201||||||FOBX|25|TS|77972-8^Earliest Date Reported to County^LN||20131205||||||FOBX|26|TS|77973-6^Earliest Date reported to State^LN||20131210||||||FOBX|27|SN|77991-8^MMWR Week^LN||^49||||||FOBX|28|DT|77992-6^MMWR Year^LN||2013||||||FOBX|29|DT|77970-2^Date First Reported to PHD^LN||20131210||||||FOBX|30|CWE|77966-0^Reporting State^LN||17^Illinois^FIPS5_2||||||FOBX|31|CWE|77967-8^Reporting County^LN||17031^Cook^FIPS6_4||||||FOBX|32|CWE|77968-6^National Reporting Jurisdiction^LN||17^Illinois^FIPS5_2||||||FOBX|33|NM|75201-4^Number of Pregnancies^LN||2||||||FOBX|34|NM|75202-2^Number of Total Live Births^LN||1||||||FOBX|35|DT|75203-0^Last Menstrual Period^LN||20130409||||||FOBX|36|CWE|75204-8^Prenatal Visit Indicator^LN||N^No^HL70136||||||FOBX|37|CWE|75179-2^Mother's HIV Status During Pregnancy^LN||165815009^HIV negative^SCT||||||FOBX|38|CWE|75180-0^Mother's Clinical Stage of Syphilis During Pregnancy^LN||UNK^Unknown^NULLFL||||||FOBX|39|CWE|75181-8^Mother's Surveillance Stage of Syphilis During Pregnancy^LN||PHC1506^Syphilis, early non-primary, non-secondary^CDCPHINVS||||||FOBX|40|CWE|75183-4^Trimester in Which Mother Received Her First Dose of Benzathine Penicillin^LN||25265005^No treatment^SCT||||||FOBX|41|CWE|75164-4^Non-treponemal Test or Treponemal Test at First Prenatal Visit^LN||N^No^HL70136||||||FOBX|42|CWE|75165-1^Non-treponemal Test or Treponemal Test at 28-32 Weeks Gestation^LN||N^No^HL70136||||||FOBX|43|CWE|75166-9^Non-treponemal Test or Treponemal Test at Delivery^LN||Y^Yes^HL70136||||||FOBX|44|CWE|LAB588^Lab Test Performed Modifier^PHINQUESTION|2|STD151^Mother's Most Recent Non-treponemal Test Finding/Information^PHINQUESTION||||||FOBX|45|CWE|INV290^Test Type^PHINQUESTION|2|5292-8^VDRL (Serum)^LN||||||FOBX|46|CWE|INV291^Test Result^PHINQUESTION|2|11214006^Reactive^SCT||||||FOBX|47|CWE|STD123^Nontreponemal Serologic syphilis test result^PHINQUESTION|2|STD128^1:128^CDCPHINVS||||||FOBX|48|DT|82772-5^Date of lab result^LN|2|20131201||||||FOBX|49|CWE|LAB588^Lab Test Performed Modifier^PHINQUESTION|3|STD152^Mother's First Treponemal Test Finding^PHINQUESTION||||||FOBX|50|CWE|INV290^Test Type^PHINQUESTION|3|24110-9^Treponema Pallidum - Enzyme immunoassay (EIA)^LN||||||FOBX|51|CWE|INV291^Test Result^PHINQUESTION|3|11214006^Reactive^SCT||||||FOBX|52|DT|82772-5^Date of lab result^LN|3|20131201||||||FOBX|53|CWE|75186-7^Vital Status^LN||237364002^Stillborn^SCT||||||FOBX|54|SN|56056-5^Birth Weight^LN||^1680|g^gram^UCUM|||||FOBX|55|SN|57714-8^Gestational Age^LN||^32|wk^week^UCUM|||||FOBX|56|CWE|75193-3^Clinical Signs of Congenital Syphilis^SCT||266128007^syphilitic skin rash^SCT||||||FOBX|57|CWE|75194-1^Long Bone X-rays for Infant^LN||UNK^Unknown^NULLFL||||||FOBX|58|CWE|75192-5^Darkfield Exam, DFA, or Special Stain Test Findings^LN||373121007^Test Not done^SCT||||||FOBX|59|CWE|LP48341-9^CSF WBC Count^LN||373121007^Test Not done^SCT||||||FOBX|60|CWE|LP69956-8^CSF Protein Level^LN||373121007^Test Not done^SCT||||||FOBX|61|CWE|75195-8^CSF VDRL Test Finding^LN||373121007^Test Not done^SCT||||||FOBX|62|CWE|75197-4^Infant Treated^LN||UNK^Unknown^NULLFL||||||FOBX|63|CWE|75207-1^Stillbirth Indicator^LN||Y^Yes^HL70136||||||FOBR|2|CSYP9700123-2^EHR^2.16.840.1.113883.19.3.2.3^ISO|CSYP9700123-2^Lab^2.16.840.1.113883.19.3.1.6^ISO|24110-9^Treponema pallidum Ab [Presence] in Serum by Immunoassay^LN|||20131202000000|||||||||121121121^^^^^^^^NPI&2.16.840.1.113883.4.6&ISO^L^^^NPI^NPI_Facility&2.16.840.1.113883.3.72.5.26&ISO^^^^^^^MD||||||20131202000000|||F||||||A53.9^Syphilis, unspecified^I10COBX|1|CWE|24110-9^Treponema pallidum Ab [Presence] in Serum by Immunoassay^LN||10828004^Positive^SCT||Negative|A^Abnormal^HL70078|||F|||20131201|||0096^Immunofluorescent antibody, direct^OBSMETHOD||20131202||||GHH Lab^L^^^^CLIA&2.16.840.1.113883.19.4.6&ISO^XX^^^1236||9876543^^^^^^^^NPI&1.3.6.1.4.1.562.2.4.1.43&ISO^^^^NPISPM|1|CSYP234561-1&EHR&2.16.840.1.113883.19.3.2.3&ISO^CSYP97001222-1&Lab&2.16.840.1.113883.19.3.1.6&ISO||119364003^Serum specimen^SCT||||368149001^Right Elbow^SCT|||P^Patient^HL70369||||||20131201|20131201170100OBR|3||CSYP9700123-2^Lab^2.16.840.1.113883.19.3.1.6^ISO|13288-6^Treponema pallidum Ab [Units/volume] in Blood by Immunofluorescence^LN|||20131202000000||||G||||||||||||||F|24110-9^Treponema pallidum Ab [Presence] in Serum by Immunoassay^LN|||CSYP9700123-2&Lab&2.16.840.1.113883.19.3.1.6&ISOOBX|1|SN|13288-6^Treponema pallidum Ab [Units/volume] in Blood by Immunofluorescence^LN||^2.3|ug/mL^MicroGrams Per MiliLiter^UCUM|||||F